Methylhexanamine (or 4-methylhexan-2-amine for those preferring its IUPAC name) is a stimulant that was only added to the WADA list in 2009. It was developed as an ingredient of nasal decongestants, and has since become a component of certain supplements (as we’ll see later), and was also used as a recreational drug in New Zealand, until it was implicated in a few serious illnesses (strokes, severe headaches and nausea) and banned.
But for our context, it is the role of methylhexanamine in sport that leads to its controversy. Having been placed on the banned list in 2009, it did not take long to “claim” some fairly high profile athletes. A group of Jamaican sprinters tested positive, but were cleared after confusion over the status of the drug. They were later sanctioned because the drug resembles another which is on the banned list (this confusion around the banned status of the drug comes up often, as you’ll see).
http://sportsscientists.com/2010/12/...ment-industry/
But for our context, it is the role of methylhexanamine in sport that leads to its controversy. Having been placed on the banned list in 2009, it did not take long to “claim” some fairly high profile athletes. A group of Jamaican sprinters tested positive, but were cleared after confusion over the status of the drug. They were later sanctioned because the drug resembles another which is on the banned list (this confusion around the banned status of the drug comes up often, as you’ll see).
http://sportsscientists.com/2010/12/...ment-industry/
Comment